Tigilanol tiglate
|
|
Tigilanol tiglate 속성
- 끓는 점
- 682.1±55.0 °C(Predicted)
- 밀도
- 1.35±0.1 g/cm3(Predicted)
- 산도 계수 (pKa)
- 10?+-.0.70(Predicted)
- InChIKey
- YLQZMOUMDYVSQR-FOWZUWBHSA-N
- SMILES
- C(O[C@H]1[C@@]2(OC(=O)[C@@H](C)CC)C(C)(C)[C@@]2([H])[C@]2([H])[C@]3([H])O[C@]3(CO)[C@@H](O)[C@@]3(O)[C@@]([H])(C=C(C)C3=O)[C@@]2(O)[C@@H]1C)(=O)/C(/C)=C/C
안전
- 위험 및 안전 성명
- 위험 및 사전주의 사항 (GHS)
그림문자(GHS): | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
신호 어: | Warning | |||||||||||||||||||||
유해·위험 문구: |
|
|||||||||||||||||||||
예방조치문구: |
|
Tigilanol tiglate C화학적 특성, 용도, 생산
개요
Tigilanol tiglate is a novel small molecule drug approved in Europe for the intratumoural treatment of non-metastatic, unresectable canine mast cell tumours. In addition, Tigilanol tiglate is also used for the treatment of multiple synchronous mast cell tumours in dogs and skin tumours in horses.용도
Tigilanol tiglate is a medication used to treat dogs with non-metastatic, skin-based (cutaneous) mast cell tumors (MCTs).Mechanism of action
The active substance in Tigilanol tiglate stimulates the action of enzymes called protein kinase C which are involved in regulating processes that can help cells grow and survive. By activating these enzymes blood supply to cells gets interrupted, resulting in the death of the cell. By injecting Stelfonta into the tumour, cancer cells will be affected, so destroying the tumour, and leaving a wound at the injection site.Tigilanol tiglate 준비 용품 및 원자재
원자재
준비 용품
Tigilanol tiglate 공급 업체
글로벌( 4)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
Hpets Biotech Company (Chongqing) Co.,ltd | +8613340353813 |
info@hanpets.com | China | 26 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 |
support@targetmol.com | United States | 19973 | 58 |
Shanghai AECOM Biotechnology Co. , Ltd. | 021-021-20956531 18116226605 |
sui@neosunpharm.com | China | 350 | 55 |
TargetMol Chemicals Inc. | 15002134094 |
marketing@targetmol.cn | China | 19696 | 58 |